ignite trial: treating alsp with trem2 receptor agonists
Published 11 days ago • 12 plays • Length 3:13Download video MP4
Download video MP3
Similar videos
-
1:14
trem2 (triggering receptor expressed on myeloid cells-2) - alzheimer's disease
-
0:23
high-throughput, fully automated optimer® development platform
-
5:31
kit replacements and expirations
-
5:51
overview of the orbita-2 trial
-
5:26
gatech phys 2212 lab 2: charged tape revisited
-
4:17
update from the x-tole open label extension study of xen1101 in focal epilepsy
-
4:35
immunity: stripline method
-
11:06
how could new treatment options improve outcomes in flt3-mutated aml?
-
27:38
[shoutang wang] anti-human trem2 induces microglia proliferation and reduces pathology in ad
-
1:59
tangible benefit for flt3-itd r/r aml on quizartinib
-
2:35
quizartinib for frontline flt3-itd aml: updated results from the quantum-first trial
-
3:23
flt3 and idh1/2 inhibitors
-
1:36
teg system by miriam lopez and raquel goodluck
-
14:12
transfusion titbits part 2- antibody basics
-
3:14
resistance mechanisms to flt3 inhibitors in aml
-
1:09
global adoption of tenecteplase for acute ischemic stroke
-
35:09
incremental use of autotransfusion (hesc 2023)
-
16:16
tenecteplase versus alteplase in acute ischemic cerebrovascular events (the trace - 2 trial)
-
2:40
an overview of the safety profile of flt3 inhibitors in aml